Suven Life Sciences Gets Patents for Neurodegenerative Drug

New Delhi: Biopharmaceutical firm Suven Life Sciences today said it has been granted one patent each by Mexico and Singapore for a drug used in the treatment of neurodegenerative diseases.   Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.   In a BSE filing, the company said it has been granted "one product patent from Mexico and one product patent from Singapore corresponding to the new chemical entiti...